UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
<MedicinalProductDefinition xmlns="http://hl7.org/fhir">
<id value="EMLA-2525-Plaster-SE-AJ-MPD"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: MedicinalProductDefinition EMLA-2525-Plaster-SE-AJ-MPD</b></p><a name="EMLA-2525-Plaster-SE-AJ-MPD"> </a><a name="hcEMLA-2525-Plaster-SE-AJ-MPD"> </a><a name="hcEMLA-2525-Plaster-SE-AJ-MPD-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/mpId</code>/SE-100001718-00011834, <code>http://ema.europa.eu/fhir/eurdId</code>/1867</p><p><b>domain</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000004 100000000012}">Human use</span></p><p><b>status</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000005003 200000005004}">Current</span></p><p><b>combinedPharmaceuticalDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073714}">Medicated plaster</span></p><p><b>indication</b>: </p><div><p>Emla plåster används vid: • Ytanestesi av intakt hud i samband med: o nålstick, t.ex. vid inläggning av perifer venkateter eller vid blodprovstagning o ytliga kirurgiska ingrepp, hos vuxna och den pediatriska populationen</p>
</div><p><b>legalStatusOfSupply</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072051 200000002239}">Medicinal product subject to medical prescription exempt for some pack sizes</span></p><p><b>classification</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000093533 100000097205}">combinations</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: EMLA 25 mg/25 mg Medicinskt plåster</p><blockquote><p><b>part</b></p><p><b>part</b>: EMLA</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000002}">Invented Name Part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 25 mg/25 mg</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000004}">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Medicinskt plåster</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000005}">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{urn:ietf:bcp:47 sv}">Swedish</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/fhir/mpId"/>
<value value="SE-100001718-00011834"/>
</identifier>
<identifier>
<system value="http://ema.europa.eu/fhir/eurdId"/>
<value value="1867"/>
</identifier>
<domain>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000004"/>
<code value="100000000012"/>
<display value="Human use"/>
</coding>
</domain>
<status>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000005003"/>
<code value="200000005004"/>
<display value="Current"/>
</coding>
</status>
<combinedPharmaceuticalDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
<code value="100000073714"/>
<display value="Medicated plaster"/>
</coding>
</combinedPharmaceuticalDoseForm>
<indication
value="Emla plåster används vid: • Ytanestesi av intakt hud i samband med: o nålstick, t.ex. vid inläggning av perifer venkateter eller vid blodprovstagning o ytliga kirurgiska ingrepp, hos vuxna och den pediatriska populationen"/>
<legalStatusOfSupply>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072051"/>
<code value="200000002239"/>
<display
value="Medicinal product subject to medical prescription exempt for some pack sizes"/>
</coding>
</legalStatusOfSupply>
<classification>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000093533"/>
<code value="100000097205"/>
<display value="combinations"/>
</coding>
</classification>
<name>
<productName value="EMLA 25 mg/25 mg Medicinskt plåster"/>
<part>
<part value="EMLA"/>
<type>
<coding>
<system value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000002"/>
<display value="Invented Name Part"/>
</coding>
</type>
</part>
<part>
<part value="25 mg/25 mg"/>
<type>
<coding>
<system value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000004"/>
<display value="Strength part"/>
</coding>
</type>
</part>
<part>
<part value="Medicinskt plåster"/>
<type>
<coding>
<system value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000005"/>
<display value="Pharmaceutical dose form part"/>
</coding>
</type>
</part>
<usage>
<country>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="sv"/>
<display value="Swedish"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>